Article
Author(s):
Baltimore-Race, that ever-sensitive subject in American culture, was the focus of a day-long meeting, "Ethnicity & Glaucoma: The Past, Present, and Future," at Johns Hopkins' Bloomberg School of Public Health.
A new era for MacTel: Clinicians react to FDA approval of revakinagene taroretcel-lwey
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Women’s eye health: The Fred Hollows Foundation's call for change this International Women’s Day
Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus
Australian Society of Ophthalmologists announces new board appointments
Cleveland Clinic’s Cole Eye Institute expands with Jeffrey and Patricia Cole Pavilion
Cyclosporine A eye drops ease ocular discomfort after cataract surgery
Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension
Tenpoint Therapeutics Ltd. appoints Carol Kearney as Chief Commercial Officer
Choroidal vascularity index offers insight into eye health after COVID-19 recovery